ACN Newswire

Tue Jul 21

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

Written by ACN Newswire

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

Read more: Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development...

ACN Newswire

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

Cutting unemployment will require an extra $70 to $90 billion in stimulus. Here’s why

How ancient seafarers and their dogs helped a humble louse conquer the world

New Hotels Join Small Luxury Hotels of the World

Yes, we've seen schools close. But the evidence still shows kids are unlikely to catch or spread coronavirus

Time well spent, not wasted: video games are boosting well-being during the coronavirus lockdown

This isn't the first global pandemic, and it won't be the last. Here's what we've learned from 4 others throughout…

Why reducing unemployment should have been a focus for NZ's well-being budget

It'd be a mistake to shut financial markets: more than ever, we need them to work

Compare the pair: key policy offerings from Labor and the Coalition in the 2019 federal election

The Benefits Of Having Great Core Stability

Where To Buy Or Sell Diamond Wedding Rings In Melbourne